Skip to content
10-Q

Quarterly Report

ANTIVIRAL TECHNOLOGIES, INC.

0001137050-11-000370

← back to feed
Filed
Nov 15, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Sep 30, 2011 150M sh
Operating Cash Flow Q3 2011 · Sep 30, 2011 −$970.84K
Operating Cash Flow Q3 2011 · Sep 30, 2010 −$61.44K
Stockholders Equity Q3 2011 · Sep 30, 2011 −$1.8M
Stockholders Equity Q3 2011 · Dec 31, 2010 −$1.52M
Total Liabilities Q3 2011 · Sep 30, 2011 $2.2M
Total Liabilities Q3 2011 · Dec 31, 2010 $1.91M
Current Assets Q3 2011 · Sep 30, 2011 $2.06K
Current Assets Q3 2011 · Dec 31, 2010 $11.03K
Total Assets Q3 2011 · Sep 30, 2011 $396.67K
Total Assets Q3 2011 · Dec 31, 2010 $384.22K
Sga Expense Q3 2011 · Sep 30, 2011 $1.65M
Sga Expense Q3 2011 · Sep 30, 2010 $113.01K
Sga Expense Q3 2011 · Sep 30, 2010 $317.61K
Net Income Q3 2011 · Sep 30, 2011 −$1.81M
Net Income Q3 2011 · Sep 30, 2010 −$113.02K
Net Income Q3 2011 · Sep 30, 2010 −$318.57K
Cash And Equivalents Q3 2011 · Sep 30, 2010 $8.33K
Cash And Equivalents Q3 2011 · Dec 31, 2009 $10.6K